A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial. (2024)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4244/eij-d-23-00567

PubMed Identifier: 38214677

Publication URI: http://europepmc.org/abstract/MED/38214677

Type: Journal Article/Review

Volume: 20

Parent Publication: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Issue: 3

ISSN: 1774-024X